HCW Biologics

HCWB · NASDAQ

$1.17−$0.06 (−4.88%)TodayMarket closed ·
Prev close $1.23

Latest news

  • Press releaseGlobe Newswire

    HCW Biologics Maintains Momentum Toward Completion of IND Application for Clinical Study to Evaluate Lead T-Cell Engager in Solid Tumors

  • Press releaseGlobe Newswire

    HCW Biologics Strengthens U.S. Patent Estate for Its Lead Clinical-Stage Immunotherapeutic HCW9302 as Alopecia Areata Treatment

  • News

    12 Health Care Stocks Moving In Tuesday's After-Market Session

  • Press releaseGlobe Newswire

    HCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial Results

  • News

    HCW Biologics Says Q1 2026 Financial Statements Should No Longer Be Relied Upon; Error In Two-Class Method For EPS Calculation Identified; Errors Constitute Material Misstatement Of EPS; EPS Of $2.19 Per Share Overstated By $0.80 Per Share For Q1 2026; Material Weakness In Technical Accounting Review Control Identified

  • News

    HCW Biologics Requests For Type B Meeting With FDA To Discuss Development, Regulatory Path For Its HCW11-018b Candidate To Treat Solid Tumors

  • Press releaseGlobe Newswire

    HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027

  • NewsVandana Singh

    Microcap HCW Biologics' Therapy Shows Early Promise Against Autoimmune Hair Loss

  • News

    HCW Biologics Says Preliminary Human Data For The First Two Dose Cohorts From Its Dose-escalating Phase 1 Trial Of HCW9302 For Alopecia Areata Shows Clinical Response After Single Dose Administration

  • Press releaseGlobe Newswire

    HCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • NewsKaustubh Bagalkote

    Why Is HCW Biologics Stock Surging On Friday?

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • NewsKaustubh Bagalkote

    Why HCW Biologics Stock Is Surging On Thursday?

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • NewsKaustubh Bagalkote

    Why HCW Biologics Stock Is Falling On Tuesday?

  • NewsKaustubh Bagalkote

    What's Going On With HCW Biologics Stock Monday?

  • NewsNabaparna Bhattacharya

    Why Is HCW Biologics Stock Gaining Today?

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • NewsAvi Kapoor

    Crude Oil Surges 3%; RBC Bearings Earnings Top Views

  • Press releaseGlobe Newswire

    Biologics Market Momentum Accelerates Across Healthcare, AI, And Global Medical Tourism

  • NewsAvi Kapoor

    Dow Tumbles 500 Points; NY Manufacturing Activity Surges In May

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • NewsMohd Haider

    HCW Biologics (HCWB) Stock Is Trending Overnight — Here's Why It Moved Over 122% In After-Hours Session

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releaseGlobe Newswire

    HCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Wednesday's Intraday Session

  • NewsAvi Kapoor

    Crude Oil Down 4%; Dollar Tree Earnings Top Views

  • NewsAvi Kapoor

    Dow Jumps Over 500 Points; NY Empire State Manufacturing Index Falls In March

  • Press releasePRNewswire

    Alopecia Areata Market Set to Expand by 2036, Due to the Emergence of Novel Drug Classes Such as OX40L Inhibitors, IL-2 Inhibitors, IL-7Rα, and Others | DelveInsight

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • News

    12 Health Care Stocks Moving In Monday's Pre-Market Session

  • Press releaseGlobe Newswire

    HCW Biologics to Participate in the 2025 Maxim Growth Summit

  • Press releaseGlobe Newswire

    HCW Biologics Inc. (NASDAQ: HCWB) Participates in Virtual Investor "What This Means" Segment About its Proprietary T-Cell Engager Program

  • Press releasePRNewswire

    Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics

  • NewsMohd Haider

    Why Is HCW Biologics Stock Surging 102% Overnight?

  • NewsAvi Kapoor

    Crude Oil Surges 2%; Chicago Fed National Activity Index Edges Lower in July

  • NewsAvi Kapoor

    US Stocks Mixed; Dow Falls Over 150 Points

  • NewsAvi Kapoor

    Crude Oil Gains 3%; US Inflation Eases In April

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • NewsAvi Kapoor

    Nasdaq Rises Over 1%; Under Armour Posts Strong Q4 Sales

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.